Search
SOLACI Congress
HomeInternational CongressesTCT 2013.

TCT 2013.

View Category
Day 3

ARCTIC-INTERRUPTION: 1 years versus 2 years of double anti-platelet

This study randomized 1259 patients to receive one year versus 2 years of double anti anti-platelet after...
solaci -
Learn More
Day 1

COREVALVE EXTREME RISK: Promising results with CoreValve in very high-risk patients

Percutaneous aortic valve implantation ( TAVI ) recently demonstrated its superiority over medical treatment in patients with...
solaci -
Learn More
Day 2

EUROMAX: Early and prolonged infusion of bivalirudin reduces mortality in AMI

Bivalirudin reduced mortality and bleeding compared to heparin and glycoprotein IIbIIIa in HORIZONS- AMI study. However there...
solaci -
Learn More
Day 2

NORDIC-BALTIC IV: 2 stents versus provisional stent in bifurcations

This study aimed to compare the strategy of 2 stents versus provisional stenting in true bifurcations.It was...
solaci -
Learn More
Day 2

TRYTON: Stent dedicated to bifurcations fails to demonstrate non-inferiority when compared with provisional

The aim of this study was to compare the results of stent TRYTON (non-drug eluting) in the...
solaci -
Learn More
Day 1

SAFE-PCI for Women: Radial versus femoral access for women

Radial access is associated with a lower rate of vascular and bleeding complications however female patients with...
solaci -
Learn More
Day 1

SORT OUT VI: Biolimus eluting stent versus zotarolimus-eluting stent; similar results

Few studies have compared head to head the 2nd generation drug eluting stents. This study randomized 1:1...
solaci -
Learn More
International Congresses

TCT 2013.

The full coverage of TCT 2013, that takes place in San Francisco City from October 27th to...
solaci -
Learn More

SOLACI is the reference organization for Latin American cardiovascular interventionism.

Last News

Severe Tricuspid Regurgitation: Surgical vs. Transcatheter Edge-to-Edge Repair

Dr. Omar Tupayachi - 0
While highly prevalent, tricuspid regurgitation is a notably undertreated valvulopathy. Its progression has been associated with higher mortality and significant disability. According to the...

ACCESS-TAVI: Comparing Post TAVR Vascular Closure Devices

Dr. Andrés Rodríguez - 0
Transcatheter aortic valve replacement (TAVR) is a well-established option to treat elderly patients with severe symptomatic aortic valve stenosis. Technical advances and device development...

Endovascular Treatment of Iliofemoral Disease for the Improvement of Heart Failure with Preserved Ejection Fraction

Dr. Omar Tupayachi - 0
Peripheral artery disease (PAD) is a significant risk factor in the development of difficult-to-treat conditions, such as heart failure with preserved ejection fraction (HFpEF)....

Institutional News

Check out the best images of the El Salvador 2024 Sessions

solaci - 0
Review the highlights of the XLIX SOLACI Regional Sessions held at the Intercontinental Hotel in San Salvador, El Salvador between November 7 and 8,...

The El Salvador 2024 Sessions are coming soon

solaci - 0
The XLIX SOLACI 2024 Regional Sessions (17th Central America & the Caribbean) are approaching, and will take place in the city of San Salvador (El Salvador)....

Check out the best images of the Arequipa 2024 Sessions

solaci - 0
Review the highlights of the XVIII SOLACI Regional Sessions held at the Hanan Hotel in Arequipa, Peru between October 3 and 4, 2024. <!-- wp:tw/bwg...

Access

Adolfo Alsina 2653 · Piso 2H · CABA · Buenos Aires · Argentina · (5411) 4954 7173 · info@solaci.org · solaci.org · Terms of Use -Privacy Policy